PP
REPL icon

PDT Partners’s Replimune Group REPL Stock Holding History

PDT Partners’s Portfolio REPL Stock Details REPL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-158,760
Closed -$1.55M – 816
2025
Q1 		$1.55M Sell
158,760
-34
-0% -$421 0.11% 310
2024
Q4 		$1.92M Buy
158,794
+24
+0% +$292 0.17% 210
2024
Q3 		$1.74M Hold
158,770
– – 0.15% 244
2024
Q2 		$1.43M Buy
+158,770
New +$1.11M 0.14% 272
2022
Q2 		– Sell
-10,898
Closed -$185K – 1120
2022
Q1 		$185K Buy
+10,898
New +$206K 0.02% 823

Other funds holding REPL

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
FIS
FCPM III Services Naarden, Netherlands $722M AUM 73.61% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $762M AUM 1,125.36% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

PDT Partners's REPL Position: Q2 2025 in Review

PDT Partners sold out of Replimune Group (REPL) in Q2 2025, closing a stake of 158,760 shares — an estimated $1.55M sold.

PDT Partners first reported a position in REPL in Q1 2022 and held it in 5 quarters. The position peaked at $1.92M in Q4 2024. 174 funds tracked by Wall St. Rank hold REPL as of Q2 2025.

  • PDT Partners reported no remaining Replimune Group position as of Q2 2025 after selling out during the quarter.
  • PDT Partners sold 158,760 Replimune Group shares in Q2 2025, an estimated $1.55M.
  • PDT Partners first reported a position in Replimune Group in Q1 2022 and held it in 5 quarters.
  • PDT Partners's Replimune Group position peaked at $1.92M in Q4 2024.
  • 174 funds tracked by Wall St. Rank held Replimune Group as of Q2 2025.

Based on PDT Partners's 13F filing for Q2 2025, filed 14 Aug 2025.